{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:55Z","timestamp":1793134135471,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This study aims to investigate the consequences of comedonecrosis omission as an exclusion criterion of the Comparison of Operative vs Monitoring and Endocrine Therapy (COMET) trial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The clinical inclusion criteria of the COMET trial were applied on women who were mammographically screened between 2007 and 2017 and had a diagnosis of low- or intermediate-grade ductal carcinoma in situ (DCIS). The percentage of ductal diameter occupied by necrosis was calculated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-six of 129 (20.2%) cases were upgraded. Larger calcification span correlated with upgrade (P = .02), with the best cutoff of 1.1 cm, and negative predictive value of 86%. When solely analyzing cases with no comedonecrosis (n = 76), none of the variables correlated with upgrade. Comedonecrosis was significantly correlated with upgrade to invasive carcinoma (P = .041), with the best cutoff of 53% of ductal diameter occupied by necrosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Results indicate that comedonecrosis and span of mammographic calcifications could be risk factors in women managed with active surveillance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqaa276","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T16:36:29Z","timestamp":1608309389000},"page":"596-606","source":"Crossref","is-referenced-by-count":6,"title":["Significance of Removing Comedonecrosis as an Exclusion Criterion in Mammary Low-Risk Ductal Carcinoma In Situ Managed in an Active Surveillance Clinical Trial"],"prefix":"10.1093","volume":"156","author":[{"given":"Haiying","family":"Zhan","sequence":"first","affiliation":[{"name":"Department of Pathology, Roswell Park Comprehensive Cancer Center , Buffalo, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Radiology, Roswell Park Comprehensive Cancer Center , Buffalo, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Biostatics, Roswell Park Comprehensive Cancer Center , Buffalo, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Biostatics, Roswell Park Comprehensive Cancer Center , Buffalo, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaer","family":"Khoury","sequence":"additional","affiliation":[{"name":"Department of Pathology, Roswell Park Comprehensive Cancer Center , Buffalo, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"2023021215111740800_CIT0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"2023021215111740800_CIT0002","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig","year":"2010","journal-title":"J Natl Cancer Inst."},{"key":"2023021215111740800_CIT0003","doi-asserted-by":"crossref","first-page":"djv263","DOI":"10.1093\/jnci\/djv263","article-title":"Trends in treatment patterns and outcomes for ductal carcinoma in situ","volume":"107","author":"Worni","year":"2015","journal-title":"J Natl Cancer Inst."},{"key":"2023021215111740800_CIT0004","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pain.2013.09.028","article-title":"Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study","volume":"155","author":"Bruce","year":"2014","journal-title":"Pain."},{"key":"2023021215111740800_CIT0005","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.pain.2012.11.015","article-title":"Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain","volume":"154","author":"Schreiber","year":"2013","journal-title":"Pain."},{"key":"2023021215111740800_CIT0006","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses\u2019 Health Study","volume":"103","author":"Collins","year":"2005","journal-title":"Cancer."},{"key":"2023021215111740800_CIT0007","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer."},{"key":"2023021215111740800_CIT0008","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer outcomes in DCIS patients without locoregional treatment","volume":"111","author":"Ryser","year":"2019","journal-title":"J Natl Cancer Inst."},{"key":"2023021215111740800_CIT0009","doi-asserted-by":"crossref","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open."},{"key":"2023021215111740800_CIT0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1309\/WH9LA543NR76Y29J","article-title":"Pathologic variables predictive of breast events in patients with ductal carcinoma in situ","volume":"128","author":"Fisher","year":"2007","journal-title":"Am J Clin Pathol."},{"key":"2023021215111740800_CIT0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-011-1387-4","article-title":"Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis","volume":"127","author":"Wang","year":"2011","journal-title":"Breast Cancer Res Treat."},{"key":"2023021215111740800_CIT0012","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology."},{"key":"2023021215111740800_CIT0013","doi-asserted-by":"crossref","first-page":"e805","DOI":"10.1016\/j.clbc.2018.04.011","article-title":"Development of a model to predict invasiveness in ductal carcinoma in situ diagnosed by percutaneous biopsy-original study and critical evaluation of the literature","volume":"18","author":"D\u00f3ria","year":"2018","journal-title":"Clin Breast Cancer."},{"key":"2023021215111740800_CIT0014","first-page":"1183","article-title":"Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy","volume":"34","author":"Hogue","year":"2014","journal-title":"Anticancer Res."},{"key":"2023021215111740800_CIT0015","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","article-title":"A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease","volume":"24","author":"Jakub","year":"2017","journal-title":"Ann Surg Oncol."},{"key":"2023021215111740800_CIT0016","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41379-019-0262-4","article-title":"Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ","volume":"32","author":"Harrison","year":"2019","journal-title":"Mod Pathol."},{"key":"2023021215111740800_CIT0017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ajcp\/aqz143","article-title":"Atypical ductal hyperplasia and those bordering on ductal carcinoma in situ should be included in the active surveillance clinical trials","volume":"153","author":"Khoury","year":"2020","journal-title":"Am J Clin Pathol."},{"key":"2023021215111740800_CIT0018","first-page":"78","article-title":"Ductal carcinoma in situ.","volume-title":"WHO Classification of Tumours: Breast Tumours","author":"Pinder","year":"2019","edition":"5"},{"key":"2023021215111740800_CIT0019","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol."},{"key":"2023021215111740800_CIT0020","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch Pathol Lab Med."},{"key":"2023021215111740800_CIT0021","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","article-title":"Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials","volume":"24","author":"Grimm","year":"2017","journal-title":"Ann Surg Oncol."},{"key":"2023021215111740800_CIT0022","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.218.2.r01fe35497","article-title":"Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates","volume":"218","author":"Jackman","year":"2001","journal-title":"Radiology."},{"key":"2023021215111740800_CIT0023","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2214\/ajr.165.3.7645467","article-title":"Stereotaxic core biopsy of impalpable spiculated breast masses","volume":"165","author":"Liberman","year":"1995","journal-title":"AJR Am J Roentgenol."},{"key":"2023021215111740800_CIT0024","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2340::AID-CNCR11>3.0.CO;2-0","article-title":"An update on core needle biopsy for radiologically detected breast lesions","volume":"78","author":"Nguyen","year":"1996","journal-title":"Cancer."},{"key":"2023021215111740800_CIT0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1148\/radiology.202.3.9051043","article-title":"Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy","volume":"202","author":"Burbank","year":"1997","journal-title":"Radiology."},{"key":"2023021215111740800_CIT0026","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archsurg.1997.01430320017002","article-title":"Histologic correlation of image-guided core biopsy with excisional biopsy of nonpalpable breast lesions","volume":"132","author":"Acheson","year":"1997","journal-title":"Arch Surg."},{"key":"2023021215111740800_CIT0027","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00000658-199806000-00017","article-title":"Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities","volume":"227","author":"Fuhrman","year":"1998","journal-title":"Ann Surg."},{"key":"2023021215111740800_CIT0028","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1001\/jama.281.17.1638","article-title":"Large-core needle biopsy of nonpalpable breast lesions","volume":"281","author":"Meyer","year":"1999","journal-title":"Jama."},{"key":"2023021215111740800_CIT0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2214\/ajr.173.1.10397131","article-title":"Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease","volume":"173","author":"Won","year":"1999","journal-title":"AJR Am J Roentgenol."},{"key":"2023021215111740800_CIT0030","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2214\/AJR.17.19244","article-title":"Patient selection for ductal carcinoma in situ observation trials: are the lesions truly low risk?","volume":"211","author":"Patel","year":"2018","journal-title":"AJR Am J Roentgenol."},{"key":"2023021215111740800_CIT0031","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejrad.2004.11.019","article-title":"Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations","volume":"54","author":"Barreau","year":"2005","journal-title":"Eur J Radiol."},{"key":"2023021215111740800_CIT0032","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2214\/ajr.159.3.1323923","article-title":"Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype","volume":"159","author":"Stomper","year":"1992","journal-title":"AJR Am J Roentgenol."},{"key":"2023021215111740800_CIT0033","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2214\/ajr.162.6.8191988","article-title":"Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings","volume":"162","author":"Evans","year":"1994","journal-title":"AJR Am J Roentgenol."},{"key":"2023021215111740800_CIT0034","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/cncr.22435","article-title":"Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates","volume":"109","author":"Houssami","year":"2007","journal-title":"Cancer."},{"key":"2023021215111740800_CIT0035","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1245\/ASO.2003.11.011","article-title":"The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy","volume":"10","author":"Hoorntje","year":"2003","journal-title":"Ann Surg Oncol."},{"key":"2023021215111740800_CIT0036","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.0819","article-title":"De-escalating breast cancer surgery for low-risk ductal carcinoma in situ\u2014reply","author":"Morrow","year":"2020;6:1117","journal-title":"JAMA Oncol."},{"key":"2023021215111740800_CIT0037","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N Engl J Med."},{"key":"2023021215111740800_CIT0038","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst."},{"key":"2023021215111740800_CIT0039","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial","volume":"31","author":"Donker","year":"2013","journal-title":"J Clin Oncol."},{"key":"2023021215111740800_CIT0040","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1023\/A:1013128213451","article-title":"Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study","volume":"12","author":"Eiermann","year":"2001","journal-title":"Ann Oncol."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/156\/4\/596\/49162266\/aqaa276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/156\/4\/596\/49162266\/aqaa276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T15:11:56Z","timestamp":1676214716000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/156\/4\/596\/6189065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,3,26]]},"published-print":{"date-parts":[[2021,9,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaa276","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,3,26]]}}}